Emily Leproust is an American scientist and entrepreneur. She is the CEO and co-founder [1] of Twist Bioscience, a public company working on DNA synthesis. The company harnesses synthetic biology, providing tools to manufacture insulin from yeast, to tackle malaria, [2] produce spider silk at scale [3] or store information on DNA. [4] [5] She was awarded the BIO Rosalind Franklin Award in 2020. [6]
Leproust earned an M.Sc. in Industrial Chemistry from the Lyon School of Industrial Chemistry [7] in 1995 and a PhD in Organic Chemistry & Nucleic Acids Chemistry from the University of Houston in 2001. [8] She worked for the company Agilent where she was Director of Applications and Chemistry R&D—Genomics before starting the company Twist Bioscience.
Leproust participated in a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. [9]
Emily Leproust is an American scientist and entrepreneur. She is the CEO and co-founder [1] of Twist Bioscience, a public company working on DNA synthesis. The company harnesses synthetic biology, providing tools to manufacture insulin from yeast, to tackle malaria, [2] produce spider silk at scale [3] or store information on DNA. [4] [5] She was awarded the BIO Rosalind Franklin Award in 2020. [6]
Leproust earned an M.Sc. in Industrial Chemistry from the Lyon School of Industrial Chemistry [7] in 1995 and a PhD in Organic Chemistry & Nucleic Acids Chemistry from the University of Houston in 2001. [8] She worked for the company Agilent where she was Director of Applications and Chemistry R&D—Genomics before starting the company Twist Bioscience.
Leproust participated in a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. [9]